A recent study by Chinese scientists has revealed the intricate molecular machinery driving energy exchange within ...

Poly adenosine diphosphate-ribose polymerase (PARP) inhibitors, a class of targeted anticancer therapies, prevent genetic ...

Pfizer Ltd has announced that the Scottish Medicines Consortium (SMC) has accepted Talzenna (talazoparib) in combination with ...

BRCA1 and BRCA2 genes play a crucial role in repairing damaged DNA. Mutations in BRCA1 and BRCA2 substantially increase the likelihood of breast and ovarian cancer, respectively. This new research ...

New findings could help identify patients likely to become resistant to anti-cancer drugs and aid exploring different ways to ...

Allarity Therapeutics (NASDAQ:ALLR – Get Free Report) announced that its board has authorized a share repurchase plan on Monday, March 3rd, RTT News reports. The company plans to buyback $5.00 million ...

These cancers are, however, quite sensitive to anticancer drugs such as poly (ADP-ribose) polymerase inhibitors (PARPi). When successful, these cancer treatments cause enough DNA damage to trigger ...

Longevity research has propelled the scientific community to concentrate on interventions that do more than simply add years ...

The nature of the sugar or substance contributing the aldehyde groups essential for these reactions was not ascertained. The present investigation indicates that ribose is responsible.